PMID- 3034375 OWN - NLM STAT- MEDLINE DCOM- 19870714 LR - 20190614 IS - 0006-8993 (Print) IS - 0006-8993 (Linking) VI - 407 IP - 1 DP - 1987 Mar 24 TI - After-hyperpolarizations produced in frog motoneurons by excitatory amino acid analogues. PG - 94-101 AB - After-hyperpolarizations (AHPs) produced in frog motoneurons by applications of the excitatory amino acid analogues quisqualate (QUIS), N-methyl-D-aspartate (NMDA), and kainate (KA) were studied in the isolated hemisected frog spinal cord using sucrose gap techniques. AHPs were present following 98% of QUIS-induced depolarizations, but were seen in only 35% and 15% of NMDA- and KA-evoked responses respectively. AHPs produced by QUIS are produced both by direct effects of QUIS on motoneuron membranes and by indirect effects mediated through a synaptic process involving interneurons. Thus, application of Mg2+, Mn2+, or tetrodotoxin (TTX) in concentrations sufficient to block synaptic transmission and interneuronal firing, reduced, but did not abolish the AHPs produced by QUIS. In contrast, NMDA- and KA-AHPs appear to be entirely mediated by indirect means as block of synaptic transmission and interneuronal firing eliminated AHPs produced by these substances. Exposure of the cord to Mn2+ after addition of TTX did not affect the size of QUIS-AHPs. In the presence of TTX, QUIS-AHPs were reduced or completely blocked by addition of dinitrophenol (DNP) and sodium cyanide, by dihydro-ouabain, by removal of K+ from the superfusate, by cooling, and by replacement of 50% of the external Na+ with Li+. The results suggest that the QUIS-AHPs are largely the result of the direct effect of the excitatory amino acid agonist on motoneuron membranes and is caused by activation of an electrogenic Na+ pump. AHPs following depolarizations evoked by NMDA and KA are presumably the result of indirect actions of these latter analogues on interneurons. FAU - Hackman, J C AU - Hackman JC FAU - Holohean, A M AU - Holohean AM FAU - Wohlberg, C J AU - Wohlberg CJ FAU - Davidoff, R A AU - Davidoff RA LA - eng GR - NS 17577/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - Netherlands TA - Brain Res JT - Brain research JID - 0045503 RN - 0 (Dinitrophenols) RN - 0 (Oxadiazoles) RN - 30KYC7MIAI (Aspartic Acid) RN - 5ACL011P69 (Ouabain) RN - 6384-92-5 (N-Methylaspartate) RN - 8OC22C1B99 (Quisqualic Acid) RN - 9NEZ333N27 (Sodium) RN - Q13SKS21MN (2,4-Dinitrophenol) RN - RWP5GA015D (Potassium) RN - SIV03811UC (Kainic Acid) SB - IM MH - 2,4-Dinitrophenol MH - Animals MH - Aspartic Acid/*analogs & derivatives/pharmacology MH - Dinitrophenols/pharmacology MH - Kainic Acid/*pharmacology MH - Membrane Potentials/drug effects MH - Motor Neurons/drug effects/*physiology MH - N-Methylaspartate MH - Ouabain/pharmacology MH - Oxadiazoles/*pharmacology MH - Potassium/physiology MH - Quisqualic Acid MH - Ranidae MH - Sodium/physiology MH - Synaptic Transmission/drug effects EDAT- 1987/03/24 00:00 MHDA- 1987/03/24 00:01 CRDT- 1987/03/24 00:00 PHST- 1987/03/24 00:00 [pubmed] PHST- 1987/03/24 00:01 [medline] PHST- 1987/03/24 00:00 [entrez] AID - 0006-8993(87)91222-4 [pii] AID - 10.1016/0006-8993(87)91222-4 [doi] PST - ppublish SO - Brain Res. 1987 Mar 24;407(1):94-101. doi: 10.1016/0006-8993(87)91222-4.